About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD27.60
- USD27.87
- USD26.59
- USD44.32
- -9.80%
- 9M
- 784.66k
- 1.59M
- 4.7B
- 12.75
- 88.50%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
